Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Pest Manag Sci ; 75(2): 527-536, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30062864

ABSTRACT

BACKGROUND: Parasitic salmon lice (Lepeophtheirus salmonis) cause high economic losses in Atlantic salmon farming. Pyrethroids, which block arthropod voltage-gated sodium channels (Nav 1), are used for salmon delousing. However, pyrethroid resistance is common in L. salmonis. The present study characterized Nav 1 homologues in L. salmonis in order to identify channel mutations associated to resistance, called kdr (knockdown) mutations. RESULTS: Genome scans identified three L. salmonis Nav 1 homologues, LsNav 1.1, LsNav 1.2 and LsNav 1.3. Arthropod kdr mutations map to specific Nav 1 regions within domains DI-III, namely segments S5 and S6 and the linker helix connecting S4 and S5. The above channel regions were amplified by RT-PCR and sequenced in deltamethrin-susceptible and deltamethrin-resistant L. salmonis. While LsNav 1.1 and LsNav 1.2 lacked nucleotide polymorphisms showing association to resistance, LsNav 1.3 showed a non-synonymous mutation in S5 of DII occurring in deltamethrin-resistant parasites. The mutation is homologous to a previously described kdr mutation (I936V, numbering according to Musca domestica Vssc1) and was present in two pyrethroid-resistant L. salmonis strains (allele frequencies of 0.800 and 0.357), but absent in two pyrethroid-susceptible strains. CONCLUSIONS: The present study indicates that a kdr-mutation in LsNaV 1.3 may contribute to deltamethrin resistance in L. salmonis. © 2018 Society of Chemical Industry.


Subject(s)
Copepoda/genetics , Insecticide Resistance/genetics , Insecticides/pharmacology , Mutation , Nitriles/pharmacology , Pyrethrins/pharmacology , Voltage-Gated Sodium Channels/genetics , Animals , Copepoda/drug effects , Salmo salar/parasitology , Sequence Analysis, Protein/veterinary , Voltage-Gated Sodium Channels/metabolism
2.
Parasit Vectors ; 11(1): 570, 2018 Oct 30.
Article in English | MEDLINE | ID: mdl-30376873

ABSTRACT

BACKGROUND: Control of the sea louse Caligus rogercresseyi in the Chilean salmonid industry is reliant on chemical treatments. Azamethiphos was introduced in 2013, although other organophosphates were previously used. In 2014, reduced sensitivity to azamethiphos was detected in the Los Lagos Region using bioassays. The main target of organophosphates is the enzyme acetylcholinesterase (AChE). Mutations in the AChE gene are the main cause of organophosphate resistance in arthropods, including other sea lice. In the present study, we aimed to characterize C. rogercresseyi AChE(s) gene(s) and to study the association between AChE variants and azamethiphos resistance in this sea louse species. METHODS: Samples of adult male and female C. rogercresseyi were collected in the Los Lagos Region in 2014. Twenty-four hour exposure bioassays with azamethiphos were performed to select sensitive and resistant lice. The full-length cDNA coding sequences encoding for two AChEs in C. rogercresseyi were molecularly characterized. One of the AChE genes was screened by direct sequencing in the azamethiphos-selected lice to search for variants. An additional louse sampling was performed before and after an azamethiphos treatment in the field in 2017 to validate the findings. RESULTS: The molecular analysis revealed two putative AChEs in C. rogercresseyi. In silico analysis and 3D modelling of the protein sequences identified both of them as invertebrate AChE type 1; they were named C. rogercresseyi AChE1a and 1b. AChE1a had the characteristics of the main synaptic AChE, while AChE1b lacked some of the important amino acids of a typical AChE. A missense change found in the main synaptic AChE (1a), F318F/V (F290 in Torpedo californica), was associated with survival of C. rogercresseyi at high azamethiphos concentrations (bioassays and field treatment). The amino acid change was located in the acyl pocket of the active-site gorge of the protein. CONCLUSIONS: The present study demonstrates the presence of two types of AChE1 genes in C. rogercresseyi. Although enzymatic assays are needed, AChE1a is most probably the main synaptic AChE. The function of AChE1b is unknown, but evidence points to a scavenger role. The AChE1a F/V318 variant is most probably involved in organophosphate resistance, and can be a good marker for resistance monitoring.


Subject(s)
Acetylcholinesterase/genetics , Antiparasitic Agents/pharmacology , Copepoda/enzymology , Fish Diseases/parasitology , Polymorphism, Genetic/genetics , Salmon/parasitology , Amino Acid Sequence , Animals , Biomarkers , Chile , Copepoda/drug effects , Copepoda/genetics , Drug Resistance , Female , Male , Organothiophosphates/pharmacology , Phylogeny , Sequence Alignment/veterinary
3.
Physiol Behav ; 132: 44-50, 2014 Jun 10.
Article in English | MEDLINE | ID: mdl-24792663

ABSTRACT

Scientific research and public debate on the welfare of animals in human custody is increasing at present. Fish are in this context mentioned with particular attention to the high numbers of individuals reared in aquaculture. Research on fish has also contributed to the understanding of individual variation in the ability to cope with stress and disease. One mediator of such variation is the brain serotonergic (5-hydroxytryptamine, 5-HT) system, which conveys physiological and behavioral responses to stress and sub-optimal rearing conditions. Here we study links between the 5-HT response, melanin-based skin pigmentation, and behavior in laboratory-reared Atlantic salmon (Salmo salar) experimentally infested with ectoparasitic sea lice (Lepeophtheirus salmonis). Lice numbers were more variable in less pigmented fish, while the neurochemical response to ectoparastic lice-increased levels of the main 5-HT catabolite 5-HIAA in the brain stem-did not differ between pigmentation groups. A strong depression of growth and locomotor activity was seen in all infested fish but less pigmented fish grew better than fish with more skin melanization regardless of infestation status. The observed combination of neurochemical and behavioral effects clearly suggest that animal welfare concerns can be added to the list of negative effects of ectoparasitic sea lice.


Subject(s)
Animal Welfare , Behavior, Animal/physiology , Brain/metabolism , Copepoda/pathogenicity , Salmo salar , Analysis of Variance , Animals , Aquaculture , Brain/anatomy & histology , Brain/parasitology , Locomotion/physiology , Melatonin/metabolism , Salmo salar/anatomy & histology , Salmo salar/parasitology , Salmo salar/physiology , Skin/parasitology , Skin/pathology , Skin Pigmentation
4.
Biochem Cell Biol ; 90(6): 769-78, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23194190

ABSTRACT

Melanogenesis is mostly studied in melanocytes and melanoma cells, but much less is known about other pigment cell systems. Liver, spleen, kidney, and other organs of lower vertebrates harbour a visceral pigment cell system with an embryonic origin that differs from that of melanocytes. In teleosts, melanin-containing cells occur in the reticulo-endothelial system and are mainly in the kidney and spleen. The Atlantic salmon (Salmo salar L.) is an ichthyic breeding species of considerable economic importance. The accumulation of pigments in salmon visceral organs and musculature adversely affects the quality of fish products and is a problem for the aquaculture industry. With the aim to reveal novel functions and behaviour of the salmonid extracutaneous pigment system, we investigated aspects of the melanogenic systems in the tissues of Atlantic salmon, as well as in SHK-1 cells, which is a long-term cell line derived from macrophages of the Atlantic salmon head-kidney. We demonstrate that a melanogenic system is present in SHK-1 cells, head-kidney, and spleen tissues. As teleosts lack lymph nodes and Peyer's patches, the head-kidney and spleen are regarded as the most important secondary lymphoid organs. The detection of tyrosinase activity in lymphoid organs indicates that a link exists between the extracutaneous pigmentary system and the immune system in salmon.


Subject(s)
Melanins/metabolism , Melanocytes/metabolism , Salmo salar/immunology , Salmo salar/metabolism , Animals , Cell Line , Head Kidney/metabolism , Kidney/metabolism , Organ Specificity , Spleen/metabolism
5.
Curr Pharm Biotechnol ; 13(6): 1095-102, 2012 May.
Article in English | MEDLINE | ID: mdl-22039799

ABSTRACT

The main indication for use of avermectins in aquaculture-produced fish is infestations with ectoparasitic copepods. The compounds ivermectin and emamectin benzoate are predominantly used as in-feed formulations on salmonid fish against copepods in the family Caligidae: Lepeophtheirus salmonis, Caligus elongatus and C. rogercresseyi. These agents are well-documented as very effective on all developmental stages of the parasites. The duration of effect can be up to 10 weeks. The safety margin for ivermectin is narrow, but better for emamectin benzoate. Environmental impact from these chemicals on bottom-dwelling and sediment-dwelling organisms occurs, but these are restricted to the immediate area around the production site. Avermectins are incompletely absorbed from the intestine of the fish and slowly excreted. They penetrate the blood-brain barrier of the fish, ivermectin more than emamectin benzoate. Resistance has developed against these agents in L. salmonis in almost all major salmon producing areas. The situation must be viewed as serious and can render these agents completely ineffective for salmon lice control.


Subject(s)
Antiparasitic Agents/therapeutic use , Fish Diseases/drug therapy , Ivermectin/analogs & derivatives , Parasitic Diseases, Animal/drug therapy , Animals , Antiparasitic Agents/pharmacokinetics , Aquaculture , Drug Residues , Drug Resistance , Fish Diseases/metabolism , Ivermectin/pharmacokinetics , Ivermectin/therapeutic use , Parasitic Diseases, Animal/metabolism
6.
Pest Manag Sci ; 62(3): 208-13, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16475215

ABSTRACT

The interpretation and importance of comparing field values of susceptibility to pesticides with a laboratory reference strain that might bear little resemblance to the actual situation in the field are problematic and a continuing subject of debate. In this paper a procedure for defining a 'normal sensitive' population from a field study of 383 individuals to provide a basis for analysing and interpreting in vitro results is described and examined. Instead of using only the 95th percentile, the upper and lower confidence limits for the 95th percentile were also compared to select the best estimation of the limit for the normal material. A field population constrained by the upper confidence limit for the 95th percentile provides appropriate descriptions of the normal material in this study. This approach should prove useful in studies of pesticide resistance in field populations.


Subject(s)
Acetylcholinesterase , Cholinesterase Inhibitors/pharmacology , Copepoda/drug effects , Pesticides/pharmacology , Toxicity Tests/methods , Acetylcholinesterase/drug effects , Animals , Confidence Intervals , Copepoda/enzymology , Drug Resistance , Female , Inhibitory Concentration 50 , Organothiophosphates/pharmacology , Reference Values
7.
Pest Manag Sci ; 60(12): 1163-70, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15578596

ABSTRACT

Acetylcholinesterase (AChE) is the target of a major pesticide family, the organophosphates, which were extensively used as control agents of sea lice on farmed salmonids in the early 1990s. From the mid-1990s the organophosphates dichlorvos and azamethiphos were seriously compromised by the development of resistance. AChE insensitive to organophosphate chemotherapeutants has been identified as a major resistance mechanism in numerous arthropod species, and in this study, target-site resistance was confirmed in the crustacean Lepeophtheirus salmonis Krøyer isolated from several fish-farming areas in Norway and Canada. A bimolecular rate assay demonstrated the presence of two AChE enzymes with different sensitivities towards azamethiphos, one that was rapidly inactivated and one that was very slowly inactivated. To our knowledge this is the first report of target-site resistance towards organophosphates in a third class of arthropods, the Crustacea.


Subject(s)
Acetylcholinesterase/metabolism , Copepoda/drug effects , Organothiophosphates/pharmacology , Animals , Aquaculture , Canada , Copepoda/enzymology , Ectoparasitic Infestations/veterinary , Female , Fish Diseases/parasitology , Insecticide Resistance/physiology , Norway , Salmon/parasitology
8.
Pest Manag Sci ; 58(6): 528-36, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12138619

ABSTRACT

In Northern Europe and Canada, the salmon louse, Lepeophtheirus salmonis (Krøyer), seriously affects the marine phase of salmon production. Although the problem is long-standing, the development of sustainable methods of pest management has been unable to keep pace with the intensification of production, leading to large-scale reliance on very few chemotherapeutants. This runs the risk of selecting for genetically determined resistance in target organisms. There are many examples of similar evolutionary adaptations in arthropod pests of arable crops, livestock and human health. Several hundred pest species are now documented as being resistant to one or more chemical classes of insecticides and acaricides. Many of these compounds are identical or closely related to ones currently employed against salmon lice. It is, therefore, opportune to consider what lessons have been learnt from contending with resistance in terrestrial organisms, the implications for sustainable use of chemotherapeutants in aquaculture, and the potential for developing effective resistance management strategies. An EU-funded project named SEARCH (QLK2-CT-2000-00809) has been initiated to explore in more detail the diagnosis, incidence, dynamics and management of resistance to chemotherapeutants in L salmonis.


Subject(s)
Antiparasitic Agents/pharmacology , Copepoda/drug effects , Drug Resistance , Fish Diseases/drug therapy , Parasitic Diseases, Animal/drug therapy , Salmon/parasitology , Animals , Antiparasitic Agents/therapeutic use , Biological Assay , Copepoda/genetics , Copepoda/physiology , Ecology , Fish Diseases/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL
...